Liraglutide Pen Injector [Victoza]

DRUG3 trials

Sponsors

University of Miami, Imperial College London, RWTH Aachen University

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseShort Bowel SyndromeType 2 DiabetesType2 Diabetes

Phase 2

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

WithdrawnNCT03371862

Imperial College LondonShort Bowel Syndrome

Start: 2017-10-20End: 2020-09-30Updated: 2020-08-14

Phase 3

Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

WithdrawnNCT04057261

RWTH Aachen UniversityCardiovascular Diseases, Type 2 Diabetes

Start: 2020-11-30End: 2022-11-30Updated: 2021-03-10

Phase 4

Liraglutide Effects on Epicardial Fat Inflammatory Genes

CompletedNCT03260881

University of MiamiCoronary Artery Disease, Type2 Diabetes

Start: 2018-09-01End: 2024-09-05Updated: 2025-07-08

Related Papers

449-P: Liraglutide Rapid Effects on Glucose and Adipose Tissue during and after CABG

Diabetes2024-06-14